[Serological survey of pandemic influenza A (H1N1) virus infection among population in Hunan Province]
- PMID: 21789845
[Serological survey of pandemic influenza A (H1N1) virus infection among population in Hunan Province]
Abstract
Objective: To understand the infection condition and analytical methods of Influenza A (H1N1) virus in the population of Hunan Province during different periods.
Methods: Quick surveys on the positive rate of Influenza A (H1N1) virus hemagglutination inhibition (HI) test have been conducted for 5 times successively from November 2009 to March 2010 in 14 medical and health institutions of Changsha city, whose results were then compared with those from the sampling surveys of whole Hunan province.
Results: 2131 subjects were involved in this study; the total population standardized rates of antibody positive investigated for 5 times were 9.32% , 14.62%, 31.08%, 28.43% and 22.80% respectively; the population of 6-17-years-old has the highest rate of antibody positive; only 9.84% of the antibody positive subjects attributed to vaccine inoculation; there was no significant difference in the standardized positive rates between the quick serological surveys and the corresponding sampling survey of Hunan province (P > 0.05).
Conclusion: The positive rate of A (H1N1) virus antibody reached the peak in late January 2010; quick investigations in small region could be used to evaluate the infection prevalence during pandemic of infectious diseases.
Similar articles
-
[A survey of levels of antibodies against influenza viruses in the population of Wuxi City].Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2011 Oct;25(5):351-4. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2011. PMID: 22338222 Chinese.
-
AS03(A)-Adjuvanted influenza A (H1N1) 2009 vaccine for adults up to 85 years of age.Clin Infect Dis. 2010 Sep 15;51(6):668-77. doi: 10.1086/655830. Clin Infect Dis. 2010. PMID: 20687838 Clinical Trial.
-
Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus.N Engl J Med. 2009 Nov 12;361(20):1945-52. doi: 10.1056/NEJMoa0906453. Epub 2009 Sep 10. N Engl J Med. 2009. PMID: 19745214
-
Immunogenicity and safety of a monovalent vaccine for the 2009 pandemic influenza virus A (H1N1) in children and adolescents.Vaccine. 2010 Aug 16;28(36):5864-70. doi: 10.1016/j.vaccine.2010.06.059. Epub 2010 Jul 13. Vaccine. 2010. PMID: 20600484 Clinical Trial.
-
Safety and immunogenicity of a trivalent single dose seasonal influenza vaccine containing pandemic A(H1N1) antigen in younger and elderly subjects: a phase III open-label single-arm study.Vaccine. 2011 Feb 1;29(6):1228-34. doi: 10.1016/j.vaccine.2010.11.092. Epub 2010 Dec 15. Vaccine. 2011. PMID: 21167116 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical